• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生后 48 小时内测量的呼气末一氧化碳浓度可预测溶血性高胆红素血症。

End-tidal carbon monoxide concentrations measured within 48 hours of birth predict hemolytic hyperbilirubinemia.

机构信息

Department of Neonatology, Shenzhen Maternity and Child Healthcare Hospital, The First School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, China.

出版信息

J Perinatol. 2024 Jun;44(6):897-901. doi: 10.1038/s41372-024-01967-7. Epub 2024 Apr 16.

DOI:10.1038/s41372-024-01967-7
PMID:38627593
Abstract

OBJECTIVES

To determine, among neonates at-risk for hyperbilirubinemia, whether measuring end-tidal carbon monoxide concentration (ETCOc) twice before 48 hours could identify those who would develop hyperbilirubinemia and differentiate hemolytic vs. non-hemolytic causes.

METHODS

Prospective study on neonates meeting criteria "at-risk for hyperbilirubinemia." Routine bilirubin measurements and 10-day follow-up were used to categorize neonates as; (1) normal (no hyperbilirubinemia, all bilirubins <95th percentile of Bhutani nomogram), (2) having hemolytic hyperbilirubinemia (bilirubin ≥95th percentile, DAT+, elevated retic, or G6PD+), or (3) having non-hemolytic hyperbilirubinemia.

RESULTS

386 neonates were enrolled. 321 (83%) did not develop hyperbilirubinemia and 65 (17%) did, of which 29 were judged hemolytic and 36 non-hemolytic. High ETCOc differentiated the hemolytic group (p < 0.001). First-day ETCOc correlated with bilirubin and with reticulocyte count (r = 0.896 and 0.878) and sensitivity and specificity for predicting hyperbilirubinemia were excellent (83% and 95%).

CONCLUSIONS

ETCO measurement in the first 48 hours after birth predicts hemolytic hyperbilirubinemia.

摘要

目的

在有发生高胆红素血症风险的新生儿中,确定在 48 小时之前测量两次呼气末一氧化碳浓度(ETCOc)是否能够识别出那些将会发生高胆红素血症的患儿,并区分溶血性与非溶血性病因。

方法

对符合“有发生高胆红素血症风险”标准的新生儿进行前瞻性研究。常规胆红素测量和 10 天随访用于将新生儿分类为:(1)正常(无高胆红素血症,所有胆红素<Bhutani 列线图第 95 百分位),(2)发生溶血性高胆红素血症(胆红素≥第 95 百分位,DAT+,升高的网织红细胞或 G6PD+),或(3)发生非溶血性高胆红素血症。

结果

共纳入 386 例新生儿。321 例(83%)未发生高胆红素血症,65 例(17%)发生了高胆红素血症,其中 29 例为溶血性,36 例为非溶血性。高 ETCOc 可区分溶血性组(p<0.001)。第 1 天的 ETCOc 与胆红素和网织红细胞计数相关(r=0.896 和 0.878),且对预测高胆红素血症的敏感性和特异性均很高(83%和 95%)。

结论

出生后 48 小时内的 ETCO 测量可预测溶血性高胆红素血症。

相似文献

1
End-tidal carbon monoxide concentrations measured within 48 hours of birth predict hemolytic hyperbilirubinemia.生后 48 小时内测量的呼气末一氧化碳浓度可预测溶血性高胆红素血症。
J Perinatol. 2024 Jun;44(6):897-901. doi: 10.1038/s41372-024-01967-7. Epub 2024 Apr 16.
2
An End-Tidal Carbon Monoxide Nomogram for Term and Late-Preterm Chinese Newborns.足月和晚期早产儿经皮脉搏碳氧血红蛋白测定值百分位曲线图的建立。
J Pediatr. 2022 Nov;250:16-21.e3. doi: 10.1016/j.jpeds.2022.07.003. Epub 2022 Jul 11.
3
Measuring End-Tidal Carbon Monoxide of Jaundiced Neonates in the Birth Hospital to Identify Those with Hemolysis.在产院测量黄疸新生儿的呼末一氧化碳以识别溶血患儿。
Neonatology. 2016;109(1):1-5. doi: 10.1159/000438482. Epub 2015 Sep 23.
4
Noninvasive Detection of Hemolysis with ETCOc Measurement in Neonates at Risk for Significant Hyperbilirubinemia.应用 ETCOc 测量技术对高胆红素血症高危新生儿进行非侵入性溶血检测。
Neonatology. 2020;117(5):612-618. doi: 10.1159/000509405. Epub 2020 Sep 7.
5
Prediction of hyperbilirubinemia in near-term and term infants.近足月儿和足月儿高胆红素血症的预测
J Perinatol. 2001 Dec;21 Suppl 1:S63-72; discussion S83-7. doi: 10.1038/sj.jp.7210638.
6
Prediction of hyperbilirubinemia in near-term and term infants.近足月和足月婴儿高胆红素血症的预测
Pediatrics. 2001 Jul;108(1):31-9. doi: 10.1542/peds.108.1.31.
7
Identification of risk for neonatal haemolysis.新生儿溶血病风险的识别。
Acta Paediatr. 2018 Aug;107(8):1350-1356. doi: 10.1111/apa.14316. Epub 2018 Apr 16.
8
End-tidal carbon monoxide is predictive for neonatal non-hemolytic hyperbilirubinemia.呼气末一氧化碳可预测新生儿非溶血性高胆红素血症。
Pediatr Int. 2001 Aug;43(4):329-33. doi: 10.1046/j.1442-200x.2001.01412.x.
9
Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia.新生儿溶血的识别:新生儿高胆红素血症出院前管理方法
Acta Paediatr. 2016 May;105(5):e189-94. doi: 10.1111/apa.13341. Epub 2016 Feb 29.
10
Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates.非裔美国葡萄糖-6-磷酸脱氢酶缺乏的新生儿中的高胆红素血症。
Pediatrics. 2004 Aug;114(2):e213-9. doi: 10.1542/peds.114.2.e213.

引用本文的文献

1
End-tidal CO corrected for ambient CO risk adjusted phototherapy threshold for the management of neonatal hyperbilirubinemia: a randomized clinical trial.用于管理新生儿高胆红素血症的经环境一氧化碳校正的呼气末一氧化碳风险调整光疗阈值:一项随机临床试验。
World J Pediatr. 2025 Aug;21(8):792-799. doi: 10.1007/s12519-025-00954-y. Epub 2025 Aug 4.
2
Peripheral blood biomarkers as differential diagnostic markers of disease severity in neonates with hyperbilirubinemia.外周血生物标志物作为高胆红素血症新生儿疾病严重程度的鉴别诊断标志物。
Heliyon. 2024 Dec 17;11(1):e41299. doi: 10.1016/j.heliyon.2024.e41299. eCollection 2025 Jan 15.

本文引用的文献

1
Higher ETCOc predicts longer phototherapy treatment in neonatal hyperbilirubinemia.较高的经皮二氧化碳分压预测新生儿高胆红素血症光疗治疗时间更长。
Front Pediatr. 2023 Apr 11;11:1154350. doi: 10.3389/fped.2023.1154350. eCollection 2023.
2
History and current standard of postnatal management in hemolytic disease of the fetus and newborn.胎儿和新生儿溶血病的历史和当前产后管理标准。
Eur J Pediatr. 2023 Feb;182(2):489-500. doi: 10.1007/s00431-022-04724-0. Epub 2022 Dec 5.
3
Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.
临床实践指南修订:孕35周及以上新生儿高胆红素血症的管理
Pediatrics. 2022 Sep 1;150(3). doi: 10.1542/peds.2022-058859.
4
An End-Tidal Carbon Monoxide Nomogram for Term and Late-Preterm Chinese Newborns.足月和晚期早产儿经皮脉搏碳氧血红蛋白测定值百分位曲线图的建立。
J Pediatr. 2022 Nov;250:16-21.e3. doi: 10.1016/j.jpeds.2022.07.003. Epub 2022 Jul 11.
5
Improvement Initiative: End-Tidal Carbon Monoxide Measurement in Newborns Receiving Phototherapy.改进计划:对接受光疗的新生儿进行潮气末一氧化碳测量。
J Pediatr. 2021 Nov;238:168-173.e2. doi: 10.1016/j.jpeds.2021.07.008. Epub 2021 Jul 11.
6
Direct antiglobulin test in the prediction of hyperbilirubinemia and predischarge bilirubin levels in infants with mother-infant blood type incompatibility.直接抗球蛋白试验在预测母婴血型不合婴儿高胆红素血症及出院前胆红素水平中的作用。
Pediatr Neonatol. 2021 Jul;62(4):406-411. doi: 10.1016/j.pedneo.2021.04.002. Epub 2021 Apr 22.
7
Neonatal hyperbilirubinemia management: Clinical assessment of bilirubin production.新生儿高胆红素血症管理:胆红素生成的临床评估。
Semin Perinatol. 2021 Feb;45(1):151351. doi: 10.1016/j.semperi.2020.151351. Epub 2020 Dec 1.
8
Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.应用产前和围产期母血清抗-A/抗-B IgG 效价定量预测 ABO 新生儿溶血病。
Pediatr Res. 2021 Jul;90(1):74-81. doi: 10.1038/s41390-020-01232-5. Epub 2020 Nov 10.
9
Cord blood bilirubin and prediction of neonatal hyperbilirubinemia and perinatal infection in newborns at risk of hemolysis.脐血胆红素与新生儿高胆红素血症和围生期感染的预测:对有溶血病风险的新生儿。
J Pediatr (Rio J). 2021 Jul-Aug;97(4):440-444. doi: 10.1016/j.jped.2020.08.009. Epub 2020 Oct 10.
10
Clinical Implication of Immunohaematological Tests in ABO haemolytic disease of newborn: Revisiting an old disease.免疫血液学检测在新生儿ABO溶血病中的临床意义:重温一种旧疾
Transfus Med. 2021 Feb;31(1):30-35. doi: 10.1111/tme.12718. Epub 2020 Sep 24.